Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective ab42-lowering agent, in mild Alzheimer's disease (AD): Results of a 12-month Phase 2 trial and 1-year follow-on study

Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective ab42-lowering agent, in mild Alzheimer's disease (AD): Results of a 12-month Phase 2 trial and 1-year follow-on study

Opis bibliograficzny
Główni autorzy:	Black, S, Wilcock, G, Haworth, J, Hendrix, S, Zavitz, K, Christensen, D, Binger, M, Bass, S, Laughlin, M, Swabb, E
Format:	Conference item
Wydane:	2006

Podobne zapisy

Efficacy and safety of MPC-7869 (R-flurbiprofen), a Selective AB42-Lowering Agent, in Alzheimer's disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study.
od: Laughlin, M, i wsp.
Wydane: (2006)

Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial
od: Wilcock, G, i wsp.
Wydane: (2005)

Efficacy and safety of tarenflurbil, a selective a beta 42-lowering agent, in Alzheimer's disease (AD): A phase 2 trial of up to 24 months of treatment
od: Black, S, i wsp.
Wydane: (2008)

Efficacy and safety of tarenflurbil (flurizan), a selective Abeta42-lowering agent, in Alzheimer's disease (AD): A phase 2 trial of up to 24 months of treatment
od: Wilcock, G, i wsp.
Wydane: (2007)

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
od: Wilcock, G, i wsp.
Wydane: (2008)

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
od: Green, R, i wsp.
Wydane: (2009)

Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.
od: Wilcock, G
Wydane: (2006)

Population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen axetil, in Chinese patients with postoperative pain
od: Zhang J, i wsp.
Wydane: (2018-11-01)

Population Pharmacokinetic Modeling of Flurbiprofen, the Active Metabolite of Flurbiprofen Axetil, in Chinese Patients with Postoperative Pain [Corrigendum]
od: Zhang J, i wsp.
Wydane: (2020-03-01)

Formulation and Evaluation of Flurbiprofen Oral Film
od: Shaimaa N. Abd-Alhammid, i wsp.
Wydane: (2017-03-01)

Formulation and Evaluation of Flurbiprofen Oral Film
od: Shaimaa N. Abd-Alhammid, i wsp.
Wydane: (2017-02-01)

Formulation and Evaluation of Flurbiprofen Oral Film
od: Shaimaa N. Abd-Alhammid, i wsp.
Wydane: (2017-03-01)

Use of Flurbiprofen Ester in 4-Dimensional Hysterosalpingography: Does Flurbiprofen Ester Relieve Pain During an Infertility Evaluation?
od: Long Tan, i wsp.
Wydane: (2024-07-01)

Population Pharmacokinetic Modeling Of Flurbiprofen, The Active Metabolite Of Flurbiprofen Axetil, In Chinese Patients With Postoperative Pain [Expression Of Concern]
od: Zhang J, i wsp.
Wydane: (2019-09-01)

The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
od: Han Yao, i wsp.
Wydane: (2021-04-01)

Ethylenediamine Salt Enhances the Solubility and Dissolution of Flurbiprofen
od: Dr. Lei Gao, i wsp.
Wydane: (2024-06-01)

Physicochemical, in vitro and in vivo evaluation of flurbiprofen microemulsion
od: MUHAMMAD NAEEM, i wsp.
Wydane: (2015-09-01)

Formulation and evaluation of co-prodrug of flurbiprofen and methocarbamol
od: Neela Bhatia, i wsp.
Wydane: (2016-06-01)

Abnormal visual search in mild cognitive impairment and Alzheimer's disease.
od: Tales, A, i wsp.
Wydane: (2005)

A Luminous Dust-obscured Tidal Disruption Event Candidate in a Star-forming Galaxy at 42 Mpc
od: Christos Panagiotou, i wsp.
Wydane: (2023-01-01)

Abnormal spatial and non-spatial cueing effects in mild cognitive impairment and Alzheimer's disease.
od: Tales, A, i wsp.
Wydane: (2005)

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
od: Katja Schmitz, i wsp.
Wydane: (2014-09-01)

Flurbiprofen ameliorates glucose deprivation-induced leptin resistance
od: Toru Hosoi, i wsp.
Wydane: (2016-09-01)

Effect of flurbiprofen axetil on postoperative delirium for elderly patients
od: Xifan Wang, i wsp.
Wydane: (2019-06-01)

FANNG-MPC: Framework for Artificial Neural Networks and Generic MPC
od: Najwa Aaraj, i wsp.
Wydane: (2024-12-01)

Control of Bioethanol Fermentation Process: NARX-Based MPC (NARX-MPC) versus Linear-Based MPC (LMPC)
od: N. Mohd, i wsp.
Wydane: (2015-09-01)

Single dose oral flurbiprofen for acute postoperative pain in adults.
od: Sultan, A, i wsp.
Wydane: (2009)

Measurement and modeling of solubilities of flurbiprofen in modified supercritical carbon dioxide.
od: Chin, Gui Jin.
Wydane: (2009)

15-LOX Inhibitors: Biochemical Evaluation of Flurbiprofen and its Derivatives
od: Saghir Abbas, i wsp.
Wydane: (2020-07-01)

Case Report: Flurbiprofen-induced Type I Kounis syndrome
od: Chao Tang, i wsp.
Wydane: (2023-11-01)

Preparation and evaluation of oral soft chewable jelly containing flurbiprofen
od: Lubna Abdalkarim Sabri, i wsp.
Wydane: (2022-01-01)

Enantioselective esterification of (R,S)-flurbiprofen catalyzed by lipase in ionic liquid
od: Ruihong Zhao, i wsp.
Wydane: (2017-01-01)

Metal organic frameworks as a drug delivery system for flurbiprofen
od: AL Haydar M, i wsp.
Wydane: (2017-09-01)

Determination of the Permeation and Penetration of Flurbiprofen into Cadaveric Human Pharynx Tissue
od: Turner R, i wsp.
Wydane: (2020-03-01)

Investigation of the parameters affecting the release of flurbiprofen from chitosan microspheres
od: Müşerref Günseli Yüksel Tilkan, i wsp.
Wydane: (2018-04-01)

Visual search in mild cognitive impairment: a longitudinal study.
od: Tales, A, i wsp.
Wydane: (2011)

Visual mismatch negativity highlights abnormal pre-attentive visual processing in mild cognitive impairment and Alzheimer's disease.
od: Tales, A, i wsp.
Wydane: (2008)

Ab initio calculations for well deformed nuclei: 40Mg and 42Si
od: Q. Yuan, i wsp.
Wydane: (2024-01-01)

Determination of the Lipophilicity of Ibuprofen, Naproxen, Ketoprofen, and Flurbiprofen with Thin-Layer Chromatography
od: Andrzej Czyrski
Wydane: (2019-01-01)

Mechanistic Investigation into Crystallization of Hydrated Co-Amorphous Systems of Flurbiprofen and Lidocaine
od: Xiaoyue Xu, i wsp.
Wydane: (2025-01-01)